Inventor · disambiguated record
Arie S. Belldegrun
Also filed as: BELLDEGRUN ARIE · BELLDEGRUN ARIE S
15 granted patents·12 pending applications·103 citations·filing 1995–2022
91Inventor score
Top patents by PatentIndex Score
27 records- 0189US8741306B2Kidney specific tumor vaccine directed against kidney tumor antigen G-250BELLDEGRUN ARIE·Filed 2009·Granted Jun 3, 2014·15 cites·21 claims
- 0284US7572891B2Kidney-specific tumor vaccine directed against kidney tumor antigen G-250UNIV CALIFORNIA·Filed 2001·Granted Aug 11, 2009·14 cites·5 claims
- 0382US8378084B2Fusion molecule based on novel TAA variantUNIV CALIFORNIA·Filed 2007·Granted Feb 19, 2013·3 cites·9 claims
- 0481US9492520B2Fusion molecule based on novel TAA variantUNIV CALIFORNIA·Filed 2016·Granted Nov 15, 2016·2 cites·16 claims
- 0581US9322010B2Fusion molecule based on novel TAA variantUNIV CALIFORNIA·Filed 2013·Granted Apr 26, 2016·3 cites·7 claims
- 0677US7267978B1Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expressionUNIV CALIFORNIA·Filed 2000·Granted Sep 11, 2007·10 cites·53 claims
- 0777US5919652ANucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereofUNIV CALIFORNIA·Filed 1995·Granted Jul 6, 1999·51 cites·13 claims
- 0876US9968664B2Fusion molecule based on novel TAA variantUNIV CALIFORNIA·Filed 2016·Granted May 15, 2018·1 cites·16 claims
- 0970US9409965B2Kidney-specific tumor vaccine directed against kidney tumor antigen G-250UNIV CALIFORNIA·Filed 2014·Granted Aug 9, 2016·0 cites·14 claims
- 1068US2022133749A1Methods and compositions for treating cancerJANSSEN ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1168US2018371411A1Kidney-specific tumor vaccine directed against kidney tumor antigen g-250UNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1266US10376567B2Fusion molecule based on TAA variantUNIV CALIFORNIA·Filed 2018·Granted Aug 13, 2019·0 cites·20 claims
- 1364US10035981B2Kidney-specific tumor vaccine directed against kidney tumor antigen G-250UNIV CALIFORNIA·Filed 2016·Granted Jul 31, 2018·0 cites·18 claims
- 1464US2014336157A1Methods and compositions for treating cancerJANSSEN ONCOLOGY INC·Filed 2014·Application pending·0 cites
- 1564US2015005268A1Methods and compositions for treating cancerJANSSEN ONCOLOGY INC·Filed 2014·Application pending·0 cites
- 1661US2020237785A1Methods and compositions for treating cancerJANSSEN ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1760US10702540B2Methods and compositions for treating cancerJANSSEN ONCOLOGY INC·Filed 2017·Granted Jul 7, 2020·0 cites·9 claims
- 1859US2017136042A1Methods and Compositions for Treating CancerJANSSEN ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 1959US2008051380A1Methods and compositions for treating cancerAUERBACH ALAN H·Filed 2007·Application pending·0 cites
- 2055US2015290221A1Methods and compositions for treating cancerJANSSEN ONCOLOGY INC·Filed 2015·Application pending·0 cites
- 2154US2009124587A1METHODS FOR TREATING CANCER USING 17alpha-HYDROXYLASE/C17,20-LYASE INHIBITORSAUERBACH ALAN H·Filed 2008·Application pending·0 cites
- 2252US2016151394A1Methods and Compositions for Treating CancerJANSSEN ONCOLOGY INC·Filed 2016·Application pending·0 cites
- 2349US2008051375A1Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the sameAUERBACH ALAN H·Filed 2007·Application pending·0 cites
- 2447US8778608B2CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinomaBELLDEGRUN ARIE S·Filed 2009·Granted Jul 15, 2014·0 cites·7 claims
- 2547US2011021470A1Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the sameCOUGAR BIOTECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 2640US6110702APSA positive regulating (PSAR) sequences and uses thereofUNIV CALIFORNIA·Filed 1997·Granted Aug 29, 2000·4 cites·40 claims
- 2731US8936914B2Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IXBUI MATTHEW H T·Filed 2003·Granted Jan 20, 2015·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Arie S. Belldegrun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →